sub filter

In contrast to M&A levels in many other sectors, deal making activity in the pharmaceutical and biotechnology industries remained strong in 2016, but is this area likely to stay hot in 2017? In the latest edition of our quarterly report series, Firmex partnered with Mergermarket to survey the current pharma and biotech landscape. We asked […]

Dealmaking activity in the pharmaceutical and biotechnology industries remained strong in 2016, in contrast to M&A levels in many other sectors. 

This case study explains how a virtual data room for pharma alliances enables the alliance to operate with an integrated process.

Touchpoint by Firmex highlights the human dimension of corporate transactions, dealmaking, and the relationships behind them.

Subscribe today!

Get TOUCHPOINT stories delivered straight to your inbox.